quinoxalines has been researched along with digoxin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, LX | 1 |
| Burstein, AH; Clark, DJ; Faessel, HM; Rohrbacher, KD; Troutman, MD; Willavize, SA | 1 |
| Aalikhani, M; Alikhani, M; Bazi, Z; Oladnabi, M; Shamsabadi, F | 1 |
1 trial(s) available for quinoxalines and digoxin
| Article | Year |
|---|---|
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.
Topics: Adolescent; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Caco-2 Cells; Digoxin; Drug Interactions; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
2 other study(ies) available for quinoxalines and digoxin
| Article | Year |
|---|---|
An integrated model for determining causes of poor oral drug absorption.
Topics: Administration, Oral; Algorithms; Anti-Anxiety Agents; Antifungal Agents; Cardiotonic Agents; Computer Simulation; Digoxin; Gastric Emptying; Griseofulvin; Intestinal Absorption; Models, Theoretical; Oxadiazoles; Particle Size; Permeability; Pharmacokinetics; Predictive Value of Tests; Quinoxalines; Solubility | 1999 |
In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques.
Topics: Aminoisobutyric Acids; Aminopterin; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Daunorubicin; Digoxin; Drug Repositioning; Gene Expression; Heart Diseases; Humans; Lactams, Macrocyclic; Leucine; Ligands; Methylergonovine; Molecular Docking Simulation; Morpholines; Proline; Quinoxalines; Sulfonamides | 2021 |